Progression from metabolically benign to at-risk obesity in perimenopausal women: A longitudinal analysis of Study of Women Across the Nation (SWAN)

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 7, 2014, Pages 2516-2525

  Khan, Unab I ^a   Wang, Dan ^a   Karvonen Gutierrez, Carrie A ^c   Khalil, Naila ^b   Ylitalo, Kelly R ^c   Santoro, Nanette ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CLIMACTERIUM; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OUTCOME ASSESSMENT; PHENOTYPE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS;

CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; PERIMENOPAUSE; RISK FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84904045070     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3259     Document Type: Article

References (46)

1. Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol. 2007;100:1654-1658. (Pubitemid 350130235)
2. Katzmarzyk PT, Janssen I, Ross R, et al. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care. 2006;29:404-409. (Pubitemid 44106526)
3. Marini MA, Succurro E, Frontoni S, et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care. 2007;30:2145-2147. (Pubitemid 47219439)
4. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168:1617-1624.
5. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care. 2011;34:210-215.
6. Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004;109:706-713. (Pubitemid 38222888)
7. Flint AJ, Hu FB, Glynn RJ, et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring). 2010;18:377-383.
8. Khan UI, Wang D, Thurston RC, et al. Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN). Atherosclerosis. 2011;217:179-186.
9. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609-1616.
10. Khan UI, Ogorodnikova AD, Xu L, et al. The adipokine profile of metabolically benign obese and at-risk normal weight postmenopausal women: the Women's Health Initiative Observational Study. Obesity (Silver Spring). 2014;22(3):786-794.
11. Sowers MF, CS, Sternsfeld B, Morganstein D, Gold EB, Greendale GA, et al. Design, survey sampling and recruitment methods of SWAN: a multi-center, multi-ethnic community-based cohort of women and the menopausal transition. In: Lobos RA, Kelsey J, eds. Menopause: Biology and Pathobiology. San Diego: Academic Press; 2000:175-188.
12. Ainsworth BE, Sternfeld B, Richardson MT, Jackson K. Evaluation of the Kaiser physical activity survey in women. Med Sci Sports Exerc. 2000;32:1327-1338. (Pubitemid 30482665)
13. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936-942. (Pubitemid 13214364)
14. Sternfeld B, Ainsworth BE, Quesenberry CP. Physical activity patterns in a diverse population of women. Prev Med. 1999;28:313-323. (Pubitemid 29372465)
15. Sutton-Tyrrell K, Wildman RP, Matthews KA, et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation. 2005;111:1242-1249. (Pubitemid 40389087)
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419. (Pubitemid 15018832)
18. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. [Erratum (2005) 112(17):e297] 2005;112:2735-2752.
19. Wildman RP, McGinn AP, Muntner P, et al. Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities. Obesity (Silver Spring). 2011;19:853-860.
20. Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002;156:714-719. (Pubitemid 35155177)
21. Nakagami T, Group DS. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia. 2004;47:385-394. (Pubitemid 38491233)
22. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 2001;86:1020-1025. (Pubitemid 32322976)
23. Standards of medical care in diabetes. Diabetes Care. 2011;34(suppl 1):S11-S61.
24. Paramsothy P, Knopp RH, Bertoni AG, et al. Association of combinations of lipid parameters with carotid intima-media thickness and coronary artery calcium in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2010;56:1034-1041.
25. Papazafiropoulou A, Skliros E, Sotiropoulos A, et al. Prevalence of target organ damage in hypertensive subjects attending primary care: C.V.P.C. study (epidemiological cardio-vascular study in primary care). BMC Fam Pract. 2011;12:75.
26. Zelzer S, Fuchs N, Almer G, et al. High density lipoprotein cholesterol level is a robust predictor of lipid peroxidation irrespective of gender, age, obesity, and inflammatory or metabolic biomarkers. Clin Chim Acta. 2011;412:1345-1349.
27. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256:2835-2838. (Pubitemid 17178361)
28. The Lipid Research Clinics. Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA. 1984;251:351-364.
29. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA. 1982;248:1465-1477.
30. Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 1996;124(suppl):S11-S20.
31. Wilson PW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL. Prediction of first events of coronary heart disease and stroke with consideration of adiposity. Circulation. 2008;118:124-130.
32. Everett BM, Kurth T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol. 2006;48:2235-2242. (Pubitemid 44855447)
33. Blackburn P, Lemieux I, Lamarche B, et al. Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women. Metab Clin Exp. 2012;61:56-64.
34. Chateau-Degat ML, Dewailly E, Poirier P, Gingras S, Egeland GM. Comparison of diagnostic criteria of the metabolic syndrome in 3 ethnic groups of Canada. Metabolism. 2008;57:1526-1532.
35. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003;108:161-165. (Pubitemid 36871297)
36. Pravenec M, Kajiya T, Zidek V, et al. Effects of human C-reactive protein on pathogenesis of features of the metabolic syndrome. Hypertension. 2011;57:731-737.
37. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation. 2006;114:1591-1598. (Pubitemid 44547429)
38. Xu Y, Whitmer K. C-reactive protein and cardiovascular disease in people with diabetes: high-sensitivity CRP testing can help assess risk for future cardiovascular disease events in this population. AmJ Nurs. 2006;106:66-72. (Pubitemid 44231605)
39. Lwow F, Dunajska K, Milewicz A, Jedrzejuk D, Kik K, Szmigiero L. Effect of moderate-intensity exercise on oxidative stress indices in metabolically healthy obese and metabolically unhealthy obese phenotypes in postmenopausal women: a pilot study. Menopause. 2011;18:646-653.
40. Johnson NA, Sachinwalla T, Walton DW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology. 2009;50:1105-1112.
41. Gan SK, Kriketos AD, Ellis BA, Thompson CH, Kraegen EW, Chisholm DJ. Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. Diabetes Care. 2003;26:1706-1713. (Pubitemid 36929108)
42. Bertoni AG, Whitt-Glover MC, Chung H, et al. The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2009;169:444-454.
43. Janssen I, Katzmarzyk PT, Ross R, Janssen I, Katzmarzyk PT, Ross R. Duration of overweight and metabolic health risk in American men and women. Ann Epidemiol. 2004;14:585-591. (Pubitemid 39221238)
44. Rexrode KM, Manson JE, Lee IM, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003;108:1688-1693. (Pubitemid 37243655)
45. Golden SH, Maguire A, Ding J, Crouse JR, Cauley JA, Zacur H, Szklo M. Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am J Epidemiol. 2002;155:437-445. (Pubitemid 34174155)
46. El Khoudary SR, Wildman RP, Matthews K, Thurston RC, Bromberger JT, Sutton-Tyrrell K. Progression rates of carotid intimamedia thickness and adventitial diameter during the menopausal transition. Menopause. 2013;20:8-14.